Carotid total plaque area as a marker of asymptomatic lower extremity arterial disease
https://doi.org/10.21886/2712-8156-2021-2-2-56-61
Abstract
Objective: to examine the prognostic value of ultrasound markers of carotid atherosclerosis in relation to the presence of asymptomatic lower extremity peripheral artery disease (PAD).
Materials and Methods: the study included 193 patients with carotid atherosclerosis. All patients underwent duplex ultrasound scanning (DUS) of carotid and lower limb arteries. The carotid plaque score (cPS) was determined as the total height of all plaques in the carotid arteries. The carotid total plaque area (cTPA) was estimated in the longitudinal position, the area of plaque was measured in the manual trace mode.
Results: asymptomatic lower extremity PAD was diagnosed in 31.6% of patients. The increase in cTPA, in contrast to cPS and the degree of carotid stenosis, was independent predictor of lower extremity PAD and was associated with an increase in the relative risk of its presence by 6.78 times (95% CI 2.48-18.5; p <0.0001). cTPA ≥42.5 mm2 made it possible to diagnose asymptomatic lower extremity PAD with a sensitivity of 70.2% and specificity of 73.0%.
Conclusion: In patients with carotid atherosclerosis among carotid atherosclerosis markers only cTPA, in contrast to cPS and the degree of carotid stenosis, had an independent predictive value regarding the presence of asymptomatic lower extremity PAD.
About the Authors
V. V. Genkel
South-Ural State Medical University
Russian Federation
Russian Federation
Vadim V. Genkel, Cand. Sci. (Med.), Associate Professor of Department of Propedeutics of Internal Medicine
Chelyabinsk
I. I. Shaposhnik
South-Ural State Medical University
Russian Federation
Russian Federation
Igor I. Shaposhnik, Dr. Sci. (Med.), Professor, Head of Department of Propedeutics of Internal Medicine
Chelyabinsk
E. V. Lebedev
South-Ural State Medical University
Russian Federation
Russian Federation
Evgeny V. Lebedev, Cand. Sci. (Med.), Associate Professor of Department of Propedeutics of Internal Medicine
Chelyabinsk
A. O. Salashenko
South-Ural State Medical University
Russian Federation
Russian Federation
Alexey O. Salashenko, Cand. Sci. (Med.), Associate Professor of Department of Propedeutics of Internal Medicine
Chelyabinsk
References
1. Bäck M, Hansson GK. Anti-inflammatory therapies for atherosclerosis. Nature Reviews Cardiology. 2015; 12(4):199-211.
2. Zhang Q, Wang A, Zhang S, Li N, Chen S, Zhang Y, et al. Asymptomatic polyvascular disease and the risks of cardiovascular events and all-cause death. Atherosclerosis. 2017; 262:1-7.
3. Aboyans V, Ricco JB, Bartelink MEL, Björck M, Brodmann M, Cohnert T, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Eur Heart J. 2018; 39(9):763-816.
4. Balakhonova TV, Pogorelova OA, Tripoten MI, Ershova A.I., Koshurnikova M.V., Rogoza А.N. Abbreviated protocol for ultrasound duplex scanning of the carotid arteries in the evaluation of preclinical atherosclerosis in order to clarify cardiovascular risk. Russian Journal of Cardiology. 2019; 24(5):62-68 [In Russ.].
5. Razzouk L, Rockman CB, Patel MR, Guo Y, Adelman MA, Riles TS, et al. Co-existence of vascular disease in different arterial beds: Peripheral artery disease and carotid artery stenosis – Data from Life Line Screening®. Atherosclerosis. 2015; 241(2):687-691.
6. Генкель В.В., Салашенко А.О. Аорто-брахиальный градиент сосудистой жесткости у пациентов с ишемической болезнью сердца и атеросклеротическим поражением артерий нижних конечностей. Клиническая фармакология и терапия. 2017. Т. 26. № 4. С. 51-54.
7. Генкель В.В., Салашенко А.О., Шапошник И.И. Aopтo-брахиальный градиент сосудистой жесткости у пациентов со стабильной ишемической болезнью сердца и атеросклерозом периферических артерий. Атеросклероз и дислипидемии. 2018. № 3 (32). С. 28-36.
8. Akazawa S, Tojikubo M, Nakano Y, Nakamura S, Tamai H, Yonemoto K, et al. Usefulness of carotid plaque (sum and maximum of plaque thickness) in combination with intima-media thickness for the detection of coronary artery disease in asymptomatic patients with diabetes. J Diabetes Investig. 2016;7(3):396-403.
9. Yerly P, Rodondi N, Viswanathan B, Riesen W, Vogt P, Bovet P. Association between conventional risk factors and different ultrasound-based markers of atherosclerosis at carotid and femoral levels in a middle-aged population. Int J Cardiovasc Imaging. 2013; 29:589-599.
10. DeMarco JK, Spence JD. Plaque assessment in the management of patients with asymptomatic carotid stenosis. Neuroimaging Clin N Am. 2016:26(1):111-127.
11. Spence JD. Measurement of carotid plaque burden. JAMA Neurol 2015; 72(4):383-384.
12. Genkel VV, Kuznetsova AS, Sumerkina VS, Salashenko AO, Shaposhnik II. The prognostic value of various carotid ultrasound parameters in patients at high and very high cardiovascular risk. Int J Cardiol. 2019;292:225-229.
13. Aboyans V, Criqui MH, Abraham P, Allison MA, Creager MA, Diehm C, et al. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation. 2012; 11(126):2890-2909.
14. Singh SS, Pilkerton CS, Shrader CD Jr, Frisbee SJ. Subclinical atherosclerosis, cardiovascular health, and disease risk: is there a case for the Cardiovascular Health Index in the primary prevention population? BMC Public Health. 2018;18(1):429.
15. Velioğlu Y, Yüksel A. Frequency of asymptomatic stenotic carotid artery disease in patients with lower extremity peripheral arterial disease. Turk J Vasc Surg. 2019; 28(2): 073-077.
16. Ahmed B, Al-Khaffaf H. Prevalence of significant asymptomatic carotid artery disease in patients with peripheral vascular disease: a meta-analysis. Eur J Vasc Endovasc Surg. 2009;37:262-71.
17. Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019; 140(11):596-646.
18. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2019 Aug 31. pii: ehz455. doi: 10.1093/eurheartj/ehz455 [In Press].
19. ten Kate GL, ten Kate GJ, van den Oord SC, Dedic A, Dharampal AS, Nieman K, et al. Carotid plaque burden as a measure of subclinical coronary artery disease in patients with heterozygous familial hypercholesterolemia. Am J Cardiol. 2013;111(9):1305-10.
20. Johri AM, Behl P, Hétu MF, Haqqi M, Ewart P, Day AG, et al. Carotid Ultrasound Maximum Plaque Height-A Sensitive Imaging Biomarker for the Assessment of Significant Coronary Artery Disease. Echocardiography. 2016; 33(2):281-9.
21. Sillesen H, Muntendam P, Adourian A, Entrekin R, Garcia M, Falk E, et al. Carotid plaque burden as a measure of subclinical atherosclerosis: comparison with other tests for subclinical arterial disease in the High Risk Plaque BioImage study. JACC Cardiovasc Imaging. 2012;5(7):681-9.
22. Ghanem AM, Hamimi AH, Matta JR, Carass A, Elgarf RM, Gharib AM, et al. Automatic Coronary Wall and Atherosclerotic Plaque Segmentation from 3D Coronary CT Angiography. Sci Rep. 2019;9(1):47.
23. Sillesen H, Sartori S, Sandholt B, Baber U, Mehran R, Fuster V. Carotid plaque thickness and carotid plaque burden predict future cardiovascular events in asymptomatic adult Americans. Eur Heart J Cardiovasc Imaging. 2018;19(9):1042-1050.
24. Selwaness M, Hameeteman R, Van 't Klooster R, Van den Bouwhuijsen Q, Hofman A, Franco OH, et al. Determinants of carotid atherosclerotic plaque burden in a stroke-free population. Atherosclerosis. 2016;255:186-192.
25. Ball S, Rogers S, Kanesalingam K, Taylor R, Katsogridakis E, McCollum C. Carotid plaque volume in patients undergoing carotid endarterectomy. Br J Surg. 2018;105(3):262-269.
Supplementary files
Review
For citations:
Genkel V.V., Shaposhnik I.I., Lebedev E.V., Salashenko A.O. Carotid total plaque area as a marker of asymptomatic lower extremity arterial disease. South Russian Journal of Therapeutic Practice. 2021;2(2):56-61. (In Russ.) https://doi.org/10.21886/2712-8156-2021-2-2-56-61
Views:
822
Email this article 